Education
About Us
Working with TipRanks
Follow Us
Medrx Co., Ltd. (JP:4586)
:4586
4586 Stock Chart & Stats
¥142.00
¥2.00(2.50%)
At close: 4:00 PM EST
¥142.00
¥2.00(2.50%)
Day’s Range― - ―
52-Week Range¥55.00 - ¥225.00
Previous CloseN/A
Volume596.00K
Average Volume (3M)2.57M
Market Cap
¥6.83B
Enterprise Value¥6.92B
Total Cash (Recent Filing)¥1.67B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta1.44
Next Earnings
Feb 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.02
Shares Outstanding59,365,100
10 Day Avg. Volume1,116,360
30 Day Avg. Volume2,574,156
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)1.64
Price to Sales (P/S)13.87
P/FCF Ratio-4.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
4586 FAQ
What was Medrx Co., Ltd.’s price range in the past 12 months?
Medrx Co., Ltd. lowest stock price was ¥55.00 and its highest was ¥225.00 in the past 12 months.
What is Medrx Co., Ltd.’s market cap?
Medrx Co., Ltd.’s market cap is ¥6.83B.
When is Medrx Co., Ltd.’s upcoming earnings report date?
Medrx Co., Ltd.’s upcoming earnings report date is Feb 06, 2026 which is in 69 days.
How were Medrx Co., Ltd.’s earnings last quarter?
Medrx Co., Ltd. released its earnings results on Nov 14, 2025. The company reported -¥2.02 earnings per share for the quarter, missing the consensus estimate of N/A by -¥2.02.
Is Medrx Co., Ltd. overvalued?
According to Wall Street analysts Medrx Co., Ltd.’s price is currently Overvalued.
Does Medrx Co., Ltd. pay dividends?
Medrx Co., Ltd. does not currently pay dividends.
What is Medrx Co., Ltd.’s EPS estimate?
Medrx Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medrx Co., Ltd. have?
Medrx Co., Ltd. has 59,365,100 shares outstanding.
What happened to Medrx Co., Ltd.’s price movement after its last earnings report?
Medrx Co., Ltd. reported an EPS of -¥2.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.563%.
Which hedge fund is a major shareholder of Medrx Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4586
Company Description
Medrx Co., Ltd.
Medrx Co., Ltd. (4586) is a Japan-based company primarily engaged in the research, development, manufacturing, and distribution of pharmaceutical products. The company specializes in transdermal drug delivery systems, which allow medications to be absorbed through the skin. Medrx Co., Ltd. focuses on providing innovative healthcare solutions across various therapeutic areas, enhancing patient compliance, and improving treatment outcomes.
Technical Analysis
Solasia Pharma KK
―
Nippon Chemiphar Co., Ltd.
―
Symbio Pharmaceuticals Limited
―
Modalis Therapeutics Corporation
―
Cyfuse Biomedical K.K.
―